Advanced Biomed (ADVB) Depreciation & Amortization (CF) (2024 - 2026)
Advanced Biomed (ADVB) posted Depreciation & Amortization (CF) of $9326.0 for Q1 2026, up 172.54% sequentially from -$12857.0 in Q4 2025, and down 58.56% YoY from $22507.0 in Q1 2025.
Advanced Biomed (ADVB) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends
Advanced Biomed has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $9326.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 58.56% year-over-year to $9326.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $320326.0 (up 44.37% YoY) and the FY2025 annual result came in at $343830.0, down 13.96% from the prior year.
- Depreciation & Amortization (CF) grew to $9326.0 in Q1 2026 per ADVB's latest filing, from -$12857.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $275865.0 in Q2 2025 and troughed at -$56760.0 in Q4 2024.
- A 4-year average of $68311.7 and a median of $52945.5 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) tumbled 198.03% in 2024, then jumped 79.24% in 2025.
- Over 4 years, Depreciation & Amortization (CF) stood at $57899.0 in 2023, then sank by 198.03% to -$56760.0 in 2024, then surged by 77.35% to -$12857.0 in 2025, then surged by 172.54% to $9326.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $9326.0, -$12857.0, and $47992.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 15.48 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 67.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 292.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 41.05 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 179.00 Mn |
| 10 | Advanced Biomed | 12.28 Mn | 12.28 Mn | - | 9,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,326.00 |
| Mar 31, 2026 | 9,326.00 |
| Dec 31, 2025 | -12,857.00 |
| Dec 31, 2025 | -12,857.00 |
| Sep 30, 2025 | 47,992.00 |
| Sep 30, 2025 | 47,992.00 |
| Jun 30, 2025 | 275,865.00 |
| Jun 30, 2025 | 275,865.00 |
| Mar 31, 2025 | 22,507.00 |
| Mar 31, 2025 | 22,507.00 |
| Dec 31, 2024 | -56,760.00 |
| Dec 31, 2024 | -56,760.00 |
| Sep 30, 2024 | 102,218.00 |
| Sep 30, 2024 | 102,218.00 |
| Jun 30, 2024 | 153,911.00 |
| Jun 30, 2024 | 153,911.00 |
| Mar 31, 2024 | 83,016.00 |
| Mar 31, 2024 | 83,016.00 |